Mandate

Vinge advised IBT on its Nasdaq Stockholm main market listing

September 10, 2018 Capital Markets and Public M&A

The shares of Infant Bacterial Therapeutics AB (publ) have been admitted to trading on the main market of Nasdaq Stockholm (Mid Cap).

 Vinge advised IBT.

The Vinge team included Erik Sjöman, Christian Lindhé and Astrid Karlsson..
 

Related

Vinge advises Got Your Back on its acquisition of Nordic Depository Services' operations within depositary services for alternative investment funds

Nordic Depositary Services provides depositary services for alternative investment funds with focus on real estate and renewable energies.
September 10, 2024

Vinge advises the sellers in conjunction with the sale of Keeros AB

Keeros AB is a fintech company that offers comprehensive solutions for invoicing, lending and leasing. The acquisition was made by Marathon Software AB which is an investment company niched towards software companies.
September 10, 2024

Vinge advises the sellers in conjunction with the sale of Konsert Strategy & IP AB

Konsert Strategy & IP AB, is a Swedish management consultancy company blending business strategy and intellectual property. The acquisition was made by Rouse International, a leading international firm offering intellectual property services.
September 10, 2024